MedPath

A Comparative Wear Test of Two Adhesives on the Unilect ™ Biotab Short Term Monitoring Electrode

Phase 3
Conditions
Healthy Subjects
Interventions
Device: Marketed electrode
Device: Modified "test" electrode
Registration Number
NCT01590368
Lead Sponsor
ConvaTec Inc.
Brief Summary

It is hypothesised that the adhesion of electrodes and acceptability of the Electrocardiogram (ECG) trace is comparable between the two groups (marketed and test products) after 30 minutes (the intended period of use) of the electrodes.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Provide written informed consent
  • Be a healthy volunteer and be over 18 years of age
  • Willing to attend two scheduled visits for application and removal of the device and adverse event review
  • Have healthy unbroken skin
Read More
Exclusion Criteria
  • Subjects with a history of sensitivity to any one of the components of the device being studied
  • Subjects who have a history of skin related disorders to the chest.
  • Subjects who are actively involved in the development, manufacturing, quality and marketing of Unomedical electrodes
  • Subjects who have any other medical condition which, according to the investigator justifies exclusion from the study
  • Subjects who have any current cardiac conditions that may lead to an abnormal ECG trace
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Marketed electrodeMarketed electrodeThe currently marketed electrodes using the current CE marked adhesive
Modified hydrogelModified "test" electrodeElectrodes with the new modified adhesive - the "test" electrodes
Primary Outcome Measures
NameTimeMethod
Product Performance : Remain in place30 minutes

Ability to remain in place for a duration of 30 minutes (as per intended use)

Product Performance: Perform30 minutes

Ability of the electrodes to perform after a duration of 30 minutes of wear (ECG tracing) as per intended use.

Secondary Outcome Measures
NameTimeMethod
Safety: Adverse Events2 days

Safety will be evaluated by the nature and frequency of adverse events, (including condition of the skin under the electrodes using the Skin Irritation Scale (Appendix 4)) and ease of removal

Skin Rating2 days

Condition of the skin under the electrodes using the Skin Irritation Scale

© Copyright 2025. All Rights Reserved by MedPath